A recent study conducted in Sweden found that GLP-1 agonists such as Ozempic and Wegovy may help reduce alcohol consumption and related harms in individuals diagnosed with alcohol use disorder. Here are three key findings:

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

Ozempic can help with blood sugar management, aid with significant weight loss, and perhaps even treat opioid use disorder. Now, there’s one more thing to add to the list: alcohol addiction. New research finds that semaglutide medications like Ozempic and Wegovy may help to lower the risk of alcohol-related issues.